These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31911115)

  • 1. The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease.
    Aimé P; Karuppagounder SS; Rao A; Chen Y; Burke RE; Ratan RR; Greene LA
    Neurobiol Dis; 2020 Mar; 136():104725. PubMed ID: 31911115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATF4 protects against neuronal death in cellular Parkinson's disease models by maintaining levels of parkin.
    Sun X; Liu J; Crary JF; Malagelada C; Sulzer D; Greene LA; Levy OA
    J Neurosci; 2013 Feb; 33(6):2398-407. PubMed ID: 23392669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease.
    Sun X; Aimé P; Dai D; Ramalingam N; Crary JF; Burke RE; Greene LA; Levy OA
    Exp Neurol; 2018 May; 303():95-107. PubMed ID: 29432724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tribble 3, a novel oxidized low-density lipoprotein-inducible gene, is induced via the activating transcription factor 4-C/EBP homologous protein pathway.
    Shang YY; Zhong M; Zhang LP; Guo ZX; Wang ZH; Zhang Y; Deng JT; Zhang W
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):51-5. PubMed ID: 19566842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating transcription factor-4 promotes neuronal death induced by Parkinson's disease neurotoxins and α-synuclein aggregates.
    Demmings MD; Tennyson EC; Petroff GN; Tarnowski-Garner HE; Cregan SP
    Cell Death Differ; 2021 May; 28(5):1627-1643. PubMed ID: 33277577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.
    Silva RM; Ries V; Oo TF; Yarygina O; Jackson-Lewis V; Ryu EJ; Lu PD; Marciniak SJ; Ron D; Przedborski S; Kholodilov N; Greene LA; Burke RE
    J Neurochem; 2005 Nov; 95(4):974-86. PubMed ID: 16135078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
    Shah M; Rajagopalan S; Xu L; Voshavar C; Shurubor Y; Beal F; Andersen JK; Dutta AK
    J Neurochem; 2014 Oct; 131(1):74-85. PubMed ID: 24848702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP
    Luo D; Zhao J; Cheng Y; Lee SM; Rong J
    Mol Neurobiol; 2018 Mar; 55(3):2258-2267. PubMed ID: 28321769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor prolyl hydroxylase domain (PHD) inhibition after contusive spinal cord injury does not improve locomotor recovery.
    Wei GZ; Saraswat Ohri S; Khattar NK; Listerman AW; Doyle CH; Andres KR; Karuppagounder SS; Ratan RR; Whittemore SR; Hetman M
    PLoS One; 2021; 16(4):e0249591. PubMed ID: 33819286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Hydroperoxy-2-decenoic acid ethyl ester protects against 6-hydroxydopamine-induced cell death via activation of Nrf2-ARE and eIF2α-ATF4 pathways.
    Inoue Y; Hara H; Mitsugi Y; Yamaguchi E; Kamiya T; Itoh A; Adachi T
    Neurochem Int; 2018 Jan; 112():288-296. PubMed ID: 28823537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA.
    Galehdar Z; Swan P; Fuerth B; Callaghan SM; Park DS; Cregan SP
    J Neurosci; 2010 Dec; 30(50):16938-48. PubMed ID: 21159964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease.
    Mercado G; Castillo V; Soto P; López N; Axten JM; Sardi SP; Hoozemans JJM; Hetz C
    Neurobiol Dis; 2018 Apr; 112():136-148. PubMed ID: 29355603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease.
    Malagelada C; Jin ZH; Jackson-Lewis V; Przedborski S; Greene LA
    J Neurosci; 2010 Jan; 30(3):1166-75. PubMed ID: 20089925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
    Fletcher EJR; Moon LDF; Duty S
    BMC Neurosci; 2019 Dec; 20(1):61. PubMed ID: 31862005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.
    Malagelada C; Ryu EJ; Biswas SC; Jackson-Lewis V; Greene LA
    J Neurosci; 2006 Sep; 26(39):9996-10005. PubMed ID: 17005863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diaminodiphenyl sulfone-induced parkin ameliorates age-dependent dopaminergic neuronal loss.
    Lee YI; Kang H; Ha YW; Chang KY; Cho SC; Song SO; Kim H; Jo A; Khang R; Choi JY; Lee Y; Park SC; Shin JH
    Neurobiol Aging; 2016 May; 41():1-10. PubMed ID: 27103513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective function of SLC30A10 induced via PERK-ATF4 pathway against 1-methyl-4-phenylpyridinium.
    Go S; Kurita H; Yokoo K; Inden M; Kambe T; Hozumi I
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1307-1313. PubMed ID: 28688763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.